Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cardiff Oncology, Inc. | Former Director | Stock Options | 125K | $326K | $2.60 | Jun 9, 2022 | Direct |
OKYO Pharma Ltd | Director | Ordinary Shares | 16.7K | $25K | $1.50 | Sep 15, 2023 | Direct |
Hepion Pharmaceuticals, Inc. | Chairman, Director | Stock Options | 99.6K | Feb 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HEPA | Hepion Pharmaceuticals, Inc. | Feb 19, 2024 | 1 | $0 | 4 | Feb 21, 2024 | Chairman, Director |
OKYO | OKYO Pharma Ltd | Sep 15, 2023 | 1 | $25K | 4 | Sep 28, 2023 | Director |
CRDF | Cardiff Oncology, Inc. | Jun 9, 2022 | 9 | $0 | 4 | Jun 9, 2022 | Former Director |
OKYO | OKYO Pharma Ltd | May 16, 2022 | 0 | $0 | 3 | May 16, 2022 | Director |
CRDF | Cardiff Oncology, Inc. | Mar 9, 2022 | 1 | $0 | 4 | Mar 10, 2022 | Director |
ACMSY | Accustem Sciences Inc. | Dec 1, 2021 | 0 | $0 | 3 | Dec 3, 2021 | Director |
CRDF | Cardiff Oncology, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |
HEPA | Hepion Pharmaceuticals, Inc. | May 18, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |